FTSE MIB
34.249,77 +310,02 (+0,91%) Dow Jones
38.239,66 +153,86 (+0,40%) Nasdaq
15.927,90 +316,14 (+2,03%) Nikkei 225
37.934,76 +306,28 (+0,81%) Petrolio
83,66 +0,09 (+0,11%) Bitcoin EUR
59.780,88 +792,02 (+1,34%)
ICU Medical, Inc. (IC7.F)
| Chiusura precedente | 89,50 |
| Aperto | 88,00 |
| Denaro | 88,50 x 6200 |
| Lettera | 90,00 x 6100 |
| Min-Max giorno | 88,00 - 88,00 |
| Intervallo di 52 settimane | 76,00 - 189,00 |
| Volume | |
| Media Volume | 0 |
| Capitalizzazione | 2,154B |
| Beta (5 anni mensile) | 0,71 |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | -1,14 |
| Prossima data utili | 07 mag 2024 |
| Rendimento e dividendo (futuro) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | 296,00 |
GlobeNewswireICU Medical to Participate at the Morgan Stanley 21st Annual Global Healthcare Conference
SAN CLEMENTE, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will participate in a fireside chat at the Morgan Stanley Annual Global Healthcare Conference at 4:30 a.m. PT (7:30 a.m. ET) on Tuesday, September 12, 2023. Company management will also be participating in one-on-one meetings on Tuesday, September 12, 2023. The fireside chat will be webc
- GlobeNewswire
ICU Medical Announces Second Quarter 2023 Results and Narrows Fiscal Year 2023 Guidance Ranges
SAN CLEMENTE, Calif., Aug. 07, 2023 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarter ended June 30, 2023. Second Quarter 2023 Results Second quarter 2023 revenue was $549.3 million, compared to $561.0 million in the same period last year. GAAP gross profit for the second quarter of 2023 was $192.3 million, as compared to $167.6 million in the same period last ye
- GlobeNewswire
ICU Medical Announces Time of Second Quarter 2023 Earnings Conference Call
SAN CLEMENTE, Calif., July 24, 2023 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its second quarter 2023 earnings release and conference call. The Company will release its second quarter 2023 results on Monday, August 7th, 2023 at approximately 4:00 p.m. ET (1:00 p.m. PT) and will be conducting a conference call concerning those results at 4:30 p.m. ET (1:30 p.m. PT) on Monday, A
